Literature DB >> 10930691

Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains.

S M Jones1, F Day, A J Stagg, E D Williamson.   

Abstract

In this paper, we describe for the first time the use of a fully recombinant sub-unit vaccine for plague. We have compared the protection afforded by the recombinant vaccine against Yersinia pestis in male and female mice of four inbred strains. We also determined the in vivo cellular memory and antibody response after one year. The recombinant vaccine was capable of inducing protective immunity, against subcutaneous and aerosol challenge, in mice from all four strains. Although, there was some breakthrough in the CBA males challenged with 10(7) median lethal dose (MLDs) the other mice regardless of sex or strain were well protected even at this extreme challenge dose. In both male and female mice, the specific IgG titres to both antigens peaked at day 28 and 35 and in female mice these titres were maintained for >1 year.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930691     DOI: 10.1016/s0264-410x(00)00108-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

Authors:  Kristin L DeBord; Deborah M Anderson; Melanie M Marketon; Katie A Overheim; R William DePaolo; Nancy A Ciletti; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.

Authors:  Luca Santi; Anatoli Giritch; Chad J Roy; Sylvestre Marillonnet; Victor Klimyuk; Yuri Gleba; Robert Webb; Charles J Arntzen; Hugh S Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

4.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 5.  Current trends in plague research: from genomics to virulence.

Authors:  Xiao-Zhe Huang; Mikeljon P Nikolich; Luther E Lindler
Journal:  Clin Med Res       Date:  2006-09

6.  An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Authors:  Sue Stacy; Amanda Pasquali; Valerie L Sexton; Angelene M Cantwell; Ellen Kraig; Peter H Dube
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols.

Authors:  Richard J Thomas; Daniel Webber; Aaron Collinge; Anthony J Stagg; Stephen C Bailey; Alejandro Nunez; Amanda Gates; Pramukh N Jayasekera; Rosa R Taylor; Steve Eley; Richard W Titball
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

Review 8.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

9.  Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice.

Authors:  Zuyun Wang; Lei Zhou; Zhizhen Qi; Qingwen Zhang; Ruixia Dai; Yonghai Yang; Baizhong Cui; Hu Wang; Ruifu Yang; Xiaoyi Wang
Journal:  Clin Vaccine Immunol       Date:  2009-11-25

10.  Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model.

Authors:  Christopher F Bosio; Clayton O Jarrett; Donald Gardner; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.